A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to results of a drug treatment trial in men whose prostate cancer had returned.

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial.

ProSense Cryoablation is now FDA approved to treat early stage, low-risk breast cancer for women 70 years and older.

A new breath test for pancreatic cancer could “revolutionise” treatment for the disease, experts have said. Scientists at Imperial College London are hoping the world-first test will turn the tide on the disease, which is notoriously hard to spot in its early stages.

The biggest message we have for our patients is that we understand lung cancer is a scary disease,” Smith said, “but if we can get this identified early, we are actually able to